American Marconi Wireless News - Moderna to Present at Upcoming Conference in November 2026

Sherilyn Smith Encourages Women to Embrace Scars as Symbols of Resilience
Korea's Severe Asthma Patients Blocked from Biologics by Restrictive Reimbursement Rules
Belgium Signs Contract for 20 Rheinmetall Skyranger Air Defence Systems
Shanghai Science and Technology Museum Signs Pacts With London and Ottawa Institutions at CIIE
Critical Elements' 10,000-Meter Summer Drill Program at Rose West Continues to Deliver Positive Results
China Explores a New Pathway for Medical AI: Bridging R&D Innovation and Clinical Adoption
Gamma Resources Announces Planned Radon Flux Baseline Survey at Mesa Arc Uranium Project in New Mexico, Provides Update on Project Timelines
Geek+ Unveils 24/7 Warehouse Autonomy Plan to Advance Self-Optimizing, Around-the-Clock Operation
Precigen Posts Strong Q3: PAPZIMEOS Net Revenue Rose 37%; Positive Cash Flow Achieved Ahead of Schedule
Zomedica Announces "Third Friday at Four" Webinar on November 20, 2026: The People Behind Zomedica - Seven Guiding Principles in Action, and Q3 Financial Results

NYSE - LSE

RBGPF	0%	75.17	$
RYCEF	8.01%	17.86	$
NGG	1.32%	84.26	$
BCC	3.21%	72.57	$
RIO	3.08%	86.39	$
CMSC	2%	20.46	$
BCE	-0.6%	21.49	$
RELX	-0.37%	40.02	$
JRI	2.51%	11.93	$
CMSD	1.61%	20.48	$
GSK	2.35%	51.54	$
VOD	0.7%	15.69	$
BTI	-1.33%	60.09	$
BP	0.13%	44.59	$
AZN	1.56%	189.39	$

Moderna to Present at Upcoming Conference in November 2026

BOULEVARD 10.11.2026

CAMBRIDGE, MA / ACCESS Newswire / November 10, 2026 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conference:

Text size:

Jefferies Global Health Care Conference, on Wednesday, November 18th 11:00am GMT

A live webcast of each of these presentations will be available under "Events and Presentations" in the Investors section of the Moderna website at investors.modernatx.com.

A replay of each webcast will be archived on Moderna's website for at least 30 days following the presentation.

About Moderna

Moderna is a pioneer and leader in the field of mRNA medicine. Through the advancement of its technology platform, Moderna is reimagining how medicines are made to transform how we treat and prevent diseases. Since its founding, Moderna's mRNA platform has enabled the development of vaccines and therapeutics across infectious diseases, cancer, rare diseases and more.

With a global team and a unique culture, driven by the company's values and mindsets, Moderna's mission is to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X, Facebook, Instagram, YouTube and LinkedIn.

Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
[email protected]

SOURCE: Moderna, Inc.

View the original press release on ACCESS Newswire

L.Mason--AMWN

Featured

Odyssey Behavioral Healthcare Launches Virtual Intensive Outpatient Mental Health Treatment for Adults

INEO Invited to 15th Annual ROTH Technology Conference in New York

Silicon Publishing Launches Prism, Bringing AI-Assisted Automation to Database Publishing

Zomedica Announces "Third Friday at Four" Webinar on November 20, 2026: The People Behind Zomedica - Seven Guiding Principles in Action, and Q3 Financial Results